| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-08 |